Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, $0.00001 par value
-
Shares outstanding
-
60,530,801
-
Total 13F shares
-
56,092,373
-
Share change
-
+1,705,383
-
Total reported value
-
$3,292,239,808
-
Put/Call ratio
-
578%
-
Price per share
-
$58.74
-
Number of holders
-
139
-
Value change
-
+$134,061,710
-
Number of buys
-
70
-
Number of sells
-
71
Institutional Holders of Apogee Therapeutics, Inc. - Common Stock, $0.00001 par value (APGE) as of Q3 2024
As of 30 Sep 2024,
Apogee Therapeutics, Inc. - Common Stock, $0.00001 par value (APGE) was held by
139 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,092,373 shares.
The largest 10 holders included
VR Adviser, LLC, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., RTW INVESTMENTS, LP, Driehaus Capital Management LLC, VANGUARD GROUP INC, Fairmount Funds Management LLC, PERCEPTIVE ADVISORS LLC, and RA CAPITAL MANAGEMENT, L.P..
This page lists
137
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.